AFFINITY ENGINEERED SERUM PROTEIN CARRIER BINDING DOMAIN

AFFINITY ENGINEERED SERUM PROTEIN CARRIER BINDING DOMAIN

The present disclosure relates to a method of modulating the half-life of a binding domain specific to a serum carrier protein by mutating the sequence and a modulated binding domain specific to a serum carrier protein.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ADAMS, Ralph, HEYWOOD, Sam Philip
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure relates to a method of modulating the half-life of a binding domain specific to a serum carrier protein by mutating the sequence and a modulated binding domain specific to a serum carrier protein.